{"symbol":"DHR","fiscalQuarter":"Q2-2012","reportDate":"2012-07-19","reportTime":"BMO","status":"reported","company":{"name":"Danaher Corporation","sector":"Health Care","industry":"Life Sciences Tools & Services"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/DHR/earnings/Q2-2012","postBrief":{"headline":"Danaher Corporation Beats on EPS, Stock Down 1.9%","keyNumbers":[{"metric":"EPS","actual":"$0.84","expected":"N/A","surprise":"+4.61%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No forward guidance data is available.","changes":[]},"whatItMeans":"Danaher Corporation reported an EPS of $0.84, exceeding expectations slightly. However, the stock fell by 1.9% on the day, indicating that investors may have been looking for stronger overall performance or guidance. The lack of revenue information and management commentary could have contributed to the stock's decline.","metaDescription":"Danaher Corporation (DHR) Q2 2012 earnings: EPS beat by 4.61%. Stock down 1.9%. Full breakdown."}}